Take Our PhysQuiz on Chronic Urticaria Apr 16, 2021 Are you caught up on advancements in treating chronic idiopathic uriticaria (CIU)? Test your knowledge on our Spotlight Series focusing on CIU. 1) The NCBI recently released recommendations for diagnosis and management of chronic idiopathic urticaria, recommends using a skin prick test as part of diagnosis to identify specific, associated allergens to CIU.* a) True b) False 2) Researchers assessed the effects and features of complete and fast response of omalizumab treatment in both spontaneous and chronic urticaria. After 6 months, what percentage of patients achieved well-controlled disease during the course of their omalizumab treatment?* a) 48% b) 58% c) 68% d) 78% 3) Findings from a randomized double-blind pilot study of patients with CIU found that testing and treating H. pylori will not improve symptoms or provide a rapid resolution of CIU.* a) True b) False 4) A recent study took a closer look at the rate of remission for CIU and found that the efficacy of omalizumab and disease severity was associated with what phenotype?* a) Neutrophils b) Eosinophils c) Basophils d) Mast cells CAPTCHA Author Mukuntha Subburayan View all posts